Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

NCT00469781 Phase 4 COMPLETED

The objective of this study is to determine if twice-daily dosing of prednisolone (Pred Forte) is as effective as four-times-daily dosing of prednisolone for the prevention of retinal thickening and cystoid macular edema (CME) when either regimen is used concomitantly with twice-daily bromfenac.

Details

Lead sponsor	Center For Excellence In Eye Care
Phase	Phase 4
Status	COMPLETED
Enrolment	95
Start date	2007-05
Completion	2008-09

Conditions

• Cystoid Macular Edema,
• Retinal Thickening

Interventions

• 2. Xibrom (Bromfenac)
• 1. Pred Forte

Primary outcomes

• Cystoid Macular Edema — 11 months

Countries

United States